HAE vs PG · P/E 35, rev $1.36B vs P/E 25, rev $84.28B
Haemonetics Corporation (HAE) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported HAE revenue for 2025-03-29 was $1.36B. Net income was $167.7M. Revenue was up 4.0% from 2024-03-30 to 2025-03-29. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
HAE currently screens at market cap $3.24B and trailing P/E 34.8. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the HAE and PG stock pages for the full models.
Not investment advice.